Equifax (EFX)
(Delayed Data from NYSE)
$302.44 USD
-0.21 (-0.07%)
Updated Sep 4, 2024 04:00 PM ET
After-Market: $302.44 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$302.44 USD
-0.21 (-0.07%)
Updated Sep 4, 2024 04:00 PM ET
After-Market: $302.44 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum D VGM
Zacks News
FI or EFX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
FI vs. EFX: Which Stock Is the Better Value Option?
Equifax (EFX) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Equifax's (EFX) revenues and earnings are likely to grow year over year, driven by the acquisition of BVS and the Brazilian credit bureau.
What Analyst Projections for Key Metrics Reveal About Equifax (EFX) Q4 Earnings
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Equifax (EFX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
Wex (WEX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Wex (WEX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Equifax (EFX) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Equifax (EFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 Financial Transaction Stocks to Gain From Favorable Consumer Spending
by Debasmita Chatterjee
The widespread uptake of digital payments and continuous pursuit of M&A strategies may aid the Financial Transaction Services space. Stocks like V, MA, FI, FIS and EFX are poised to benefit from the favorable industry trends.
FI vs. EFX: Which Stock Is the Better Value Option?
by Zacks Equity Research
FI vs. EFX: Which Stock Is the Better Value Option?
Reasons Why You Should Hold on to Equifax (EFX) Stock Now
by Zacks Equity Research
Equifax (EFX) benefits from its client base and ability to deliver personalized insights and decision-making solutions.
FI vs. EFX: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
FI vs. EFX: Which Stock Is the Better Value Option?
Equifax (EFX) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
The Zacks Analyst Blog Highlights Microsoft, Booking Holdings, Bristol-Myers Squibb, Equifax hand First Solar
by Zacks Equity Research
Microsoft, Booking Holdings, Bristol-Myers Squibb, Equifax hand First Solar are included in this Analyst Blog.
Top Stock Reports for Microsoft, Booking Holdings & Bristol-Myers Squibb
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Booking Holdings Inc. (BKNG) and Bristol-Myers Squibb Company (BMY).
NVEI or EFX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
NVEI vs. EFX: Which Stock Is the Better Value Option?
Steelcase Inc. (SCS) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Steelcases (SCS) third-quarter fiscal 2024 earnings and revenues are expected to have decreased year over year.
FactSet (FDS) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
FactSet's (FDS) first-quarter fiscal 2024 earnings and revenues are expected to have increased year over year.
DocuSign (DOCU) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
DocuSign's (DOCU) third-quarter fiscal 2024 earnings and revenues are expected to increase year over year.
Fiserv (FI) Up 9.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Fiserv (FI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Equifax (EFX) Up 12% Since Last Earnings Report?
by Zacks Equity Research
Equifax (EFX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Maximus (MMS) Q4 Earnings Fall Short of Estimates, Decline Y/Y
by Zacks Equity Research
Maximus (MMS) fourth-quarter fiscal 2023 revenues increase 7.1% year over year.
Stantec (STN) Stock Rises 11.4% Since Q3 Earnings Beat Estimates
by Zacks Equity Research
Stantec's (STN) third-quarter 2023 earnings surge 26.9% year over year. However, revenues fall 13.1% in the same time frame.
WEX or EFX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
WEX vs. EFX: Which Stock Is the Better Value Option?
ICF International (ICFI) Stock Up 8.2% on Q3 Earnings Beat
by Zacks Equity Research
ICF International (ICFI) third-quarter 2023 earnings and revenues surge 12.4% and 7.2%, respectively.
Genpact's (G) Stock Declines 8% Despite Q3 Earnings Beat
by Zacks Equity Research
Genpact's (G) third-quarter 2023 revenues increase year over year.
Maximus (MMS) to Post Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Maximus' (MMS) fourth-quarter fiscal 2023 revenues are expected to have increased year over year.
Green Dot (GDOT) Stock Plunges 34% Since Q3 Earnings Miss
by Zacks Equity Research
Green Dot (GDOT) third-quarter 2023 earnings plunge 68.2% while revenue inch up 1.4% year over year.